U.S. Employers Dropping GLP-1 Drug Coverage as Healthcare Costs Rise
Source Summary
Approximately 14% of U.S. employers have already dropped or plan to drop coverage of GLP-1 drugs in 2027 due to rising healthcare costs. The move reflects employer concerns about the expense of these medications as part of their health benefit programs.
Why it matters
Employer coverage decisions directly affect patient access to GLP-1 medications and may shift costs to employees or reduce treatment availability.
